Brief: Pliant Therapeutics Inc Reports Q3 Revenue Of $1.5 Million
Nov 8 (Reuters) - Pliant Therapeutics Inc PLRX.O :
* PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
THIRD
QUARTER 2022 FINANCIAL RESULTS
* QTRLY REVENUE $1.5 MILLION VERSUS $1.6 MILLION
* QTRLY LOSS PER SHARE $0.65
* Q3 EARNINGS PER SHARE VIEW $-0.74, REVENUE VIEW $1.6
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9WgJx5
Further company coverage: PLRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals